XML 38 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Schedule of Quantitative Disclosure of the Fair Value for Each Major Category of Assets and Liabilities
The following financial instruments are remeasured at fair value on a recurring basis:
Fair Value Measurements as of
September 30, 2021December 31, 2020
Cash Flow Hedges: (a)
Level 1Level 2Level 3Level 1Level 2Level 3
Derivative interest rate liabilities (b)(c)$— $(7,661)$— $— $(12,449)$— 
(a)During the twelve months subsequent to September 30, 2021, an estimated $4,229 of derivative interest rate liabilities recognized in accumulated comprehensive loss will be reclassified into earnings.
(b)The Company's and IAGM's derivative liabilities are recognized as a part of other liabilities and investment in unconsolidated entities, respectively, on the Company's condensed consolidated balance sheets.
(c)As of September 30, 2021 and December 31, 2020, the Company determined that the credit valuation adjustments associated with nonperformance risk are not significant to the overall valuation of its derivatives. As a result, the Company's derivative valuations in their entirety are classified as Level 2 of the fair value hierarchy.
Schedule of Fair Value of Financial Instruments Presented at Carrying Values
The table below summarizes the estimated fair value of financial instruments presented at carrying values in the Company's condensed consolidated financial statements as of September 30, 2021 and December 31, 2020:
September 30, 2021December 31, 2020
Carrying ValueEstimated Fair ValueCarrying ValueEstimated Fair Value
Mortgages payable$106,288 $105,217 $107,261 $106,494 
Term loans$400,000 $400,038 $400,000 $400,055 
Revolving line of credit$— $— $50,000 $50,032